Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Sep;73(9):3278–3282. doi: 10.1073/pnas.73.9.3278

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

T E Carey, T Takahashi, L A Resnick, H F Oettgen, L J Old
PMCID: PMC431008  PMID: 1067619

Abstract

We studied how frequently patients with malignant melanoma have specific antibody to cell surface antigens of cultured autologous melanoma cells as demonstrated by mixed hemadsorption assays. Of 35 patients studied over periods ranging from 1 to 36 months with Stage II, III, and IV disease, two showed consistent and high titered reactivity against autologous melanoma cells, two showed less consistent and intermediate reactivity, seven showed sporatic, low titered reactivity, and the remainder were consistently negative. A detailed analysis was carried out with the sera of one patient with sufficiently high titer against autologous melanoma cells. By direct tests and by absorption analysis with a variety of melanoma and nonmelanoma cell lines which included autologous fibroblasts, the antigen could not be demonstrated on any cell type other than the autologous melanoma.

Full text

PDF
3278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bean M. A., Bloom B. R., Herberman R. B., Old L. J., Oettgen H. F., Klein G., Terry W. D. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res. 1975 Oct;35(10):2902–2913. [PubMed] [Google Scholar]
  2. Bodurtha A. J., Chee D. O., Laucius J. F., Mastrangelo M. J., Prehn R. T. Clinical and immunological significance of human melanoma cytotoxic antibody. Cancer Res. 1975 Jan;35(1):189–193. [PubMed] [Google Scholar]
  3. Bubeník J., Jakoubková J., Krákora P., Baresová M., Helbich P., Viklický V., Malasková V. Cellular immunity to renal carcinomas in man. Int J Cancer. 1971 Nov 15;8(3):503–513. doi: 10.1002/ijc.2910080319. [DOI] [PubMed] [Google Scholar]
  4. Cikes M., Friberg S., Jr, Klein G. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst. 1973 Feb;50(2):347–362. doi: 10.1093/jnci/50.2.347. [DOI] [PubMed] [Google Scholar]
  5. Clarkson B., Strife A., De Harven E. Continuous culture of seven new cell lines (SK-L1 to 7) from patients with acute leukemia. Cancer. 1967 Jun;20(6):926–947. doi: 10.1002/1097-0142(196706)20:6<926::aid-cncr2820200603>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  6. Cornain S., de Vries J. E., Collard J., Vennegoor C., van Wingerden I., Rümke P. Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer. 1975 Dec 15;16(6):981–997. doi: 10.1002/ijc.2910160612. [DOI] [PubMed] [Google Scholar]
  7. ESPMARK A., FAGRAEUS A. Detection of antigens in tissue culture with the aid of mixed hemadsorption. Acta Pathol Microbiol Scand Suppl. 1962;Suppl 154:258–262. [PubMed] [Google Scholar]
  8. Ioachim H. L., Dorsett B., Sabbath M., Keller S. Loss and recovery of phenotypic expression of Gross leukaemia virus. Nat New Biol. 1972 Jun 14;237(76):215–218. doi: 10.1038/newbio237215b0. [DOI] [PubMed] [Google Scholar]
  9. Irie K., Irie R. F., Morton D. L. Detection of antibody and complement complexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques. Cancer Res. 1975 May;35(5):1244–1248. [PubMed] [Google Scholar]
  10. Lewis M. G., Phillips T. M. The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer. 1972 Jul 15;10(1):105–111. doi: 10.1002/ijc.2910100114. [DOI] [PubMed] [Google Scholar]
  11. Lewis M. G. Possible immunological factors in human malignant melanoma in Uganda. Lancet. 1967 Oct 28;2(7522):921–922. doi: 10.1016/s0140-6736(67)90236-x. [DOI] [PubMed] [Google Scholar]
  12. Metzgar R. S., Oleinick S. R. The study of normal and malignant cell antigens by mixed agglutination. Cancer Res. 1968 Jul;28(7):1366–1371. [PubMed] [Google Scholar]
  13. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  14. Nairn R. C., Nind A. P., Guli E. P., Davies D. J., Little J. H., Davis N. C., Whitehead R. H. Anti-tumor immunoreactivity in patients with malignant melanoma. Med J Aust. 1972 Feb 26;1(9):397–403. [PubMed] [Google Scholar]
  15. O'Toole C., Stejskal V., Perlmann P., Karlsson M. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. J Exp Med. 1974 Mar 1;139(3):457–466. doi: 10.1084/jem.139.3.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Oettgen H. F., Aoki T., Old L. J., Boyse E. A., de Harven E., Mills G. M. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst. 1968 Oct;41(4):827–843. [PubMed] [Google Scholar]
  17. Old L. J., Boyse E. A., Stockert E. The G (Gross) leukemia antigen. Cancer Res. 1965 Jul;25(6):813–819. [PubMed] [Google Scholar]
  18. Romsdahl M. M., Cox I. S. Human malignant melanoma antibodies demonstrated by immunofluorescence. Arch Surg. 1970 Apr;100(4):491–497. doi: 10.1001/archsurg.1970.01340220167028. [DOI] [PubMed] [Google Scholar]
  19. The T. H., Huiges H. A., Schraffordt Koops H., Lamberts H. B., Nieweg H. O. Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines. Ann N Y Acad Sci. 1975 Jun 30;254:528–540. doi: 10.1111/j.1749-6632.1975.tb29200.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES